1. Gulati M, Levy PD, Mukherjee D, et al. AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis ofchest pain: executive summary: a report of the American college ofcardiology/American heart association joint committee on clinicalpractice guidelines. Circulation. 2021;144(22):e368-454.
2. Hansen B, Holtzman JN, Juszczynski C, et al. Ischemia with NoObstructive Arteries (INOCA): A Review of the Prevalence, Diagnosisand Management. Curr Probl Cardiol. 2023;48(1):101420.
3. Bastiany A, Pacheco C, Sedlak T, et al. A Practical Approach to InvasiveTesting in Ischemia With No Obstructive Coronary Arteries (INOCA).CJC Open. 2022;4(8):709-720.
4. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacyand safety of new oral anticoagulants with warfarin in patients withatrial fibrillation: a meta-analysis of randomised trials. Lancet (London,England). 2014;383:955-962.
5. Saglietto A, Varbella V, Ballatore A, Xhakupi H, Ferrari GM, AnselminoM. Prognostic implications of atrial fibrillation in patients with stablecoronary artery disease: a systematic review and meta-analysis ofadjusted observational studies. Rev Cardiovasc Med. 2021;22(2):439-444.
6. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guidelinefor the management of patients with atrial fibrillation: a report of theAmerican College of Cardiology/American Heart Association TaskForce on Practice Guidelines and the Heart Rhythm Society. J Am CollCardiol. 2014;64(21):e1-e76.
7. Miller JD, Aronis KN, Chrispin J, et al. Obesity, exercise, obstructivesleep apnea, and modifiable atherosclerotic cardiovascular disease riskfactors in atrial fibrillation. J Am Coll Cardiol. 2015;66(25):2899-2906.
8. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatorydisorder? Eur Heart J. 2006;27:136-149.
9. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiationand perpetuation of atrial fibrillation: A systematic review of thepublished data. J Am Coll Cardiol. 2007;50:2021-2028.
10. Ozaydin M, Peker O, Erdogan D, et al. Oxidative status, inflammation,and postoperative atrial fibrillation with metoprolol vs carvedilolor carvedilol plus N-acetyl cysteine treatment. Clin Cardiol.2014;37(5):300-306.
11. Thompson AE, Hirsch GM, Pearson GJ. Assessment of new onsetpostcoronary artery bypass surgery atrial fibrillation: current practicepattern review and the development of treatment guidelines. J ClinPharm Ther. 2002;27(1):21-37.
12. Magnani JW, Mazzini MJ, Sullivan LM, Williamson M, EllinorPT, Benjamin EJ. P-wave indices, distribution and quality controlassessment (from the Framingham Heart Study). Ann NoninvasiveElectrocardiol. 2010;15(1):77-84.
13. Liu Z, Hayano M, Hirata T, et al. [Abnormalities of electrocardiographicP wave morphology and the relationship to electrophysiologicalparameters of the atrium in patients with idiopathic paroxysmal atrialfibrillation]. J Cardiol. 1998;32(3):189-196.
14. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiacchamber quantification by echocardiography in adults: an updatefrom the American Society of Echocardiography and the EuropeanAssociation of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28: 1-39.e14.
15. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascularoutcomes in women with nonobstructive coronary artery disease: areport from the Women’s Ischemia Syndrome Evaluation Study andthe St James Women Take Heart Project. Arch Intern Med 2009;169(9):843-850.
16. Schumann CL, Mathew RC, Dean JL, et al. Functional and EconomicImpact of INOCA and Influence of Coronary MicrovascularDysfunction. JACC Cardiovasc Imaging 2021;14(7):1369-1379.
17. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographicmarkers for the prediction of paroxysmal idiopathic atrial fibrillation.Am Heart J. 1998;135:733-738.
18. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, et al. Clinical andelectrocardiographic predictors of recurrent atrial fibrillation. PacingClin Electrophysiol. 2000; 23: 352-358.
19. Aytemir K, Ozer N, Atalar E, et al. P wave dispersion on 12-leadelectrocardiography in patients with paroxysmal atrial fibrillation.Pacing Clin Electrophysiol. 2000;23:1109-1112.
20. Ozuğuz U, Ergün G, Işık S, et al. Association between C-reactiveprotein, carotid intimamedia thickness and P-wave dispersion in obesepremenopausal women: an observational study. Anadolu Kardiyol Derg.2012;12:40-46.
21. Turkmen M, Barutcu I, Esen AM, Karakaya O, Esen O, BasaranY. Effect of slow coronary flow on P-wave duration and dispersion.Angiology 2007;58:408-412.
22. Gunduz H, Binak E, Arinc H, et al. The relationship between P wavedispersion and diastolic dysfunction. Tex Heart Inst J. 2005;32:163-167.
23. Tukek T, Akkaya V, Atilgan D, et al. Effect of left atrial size andfunction on P-wave dispersion:A study in patients with paroxysmalatrial fibrillation. Clin Cardiol 2001;24, 676-680.
24. Dilaveris PE, Gialafos EJ, Chrissos D, et al. Detection of hypertensivepatients at risk for paroxysmal atrial fibrillation during sinus rhythmby computer assisted P wave analysis. J Hypertens 1999;17:1463-1470.
25. Hashemi Jazi M, Amirpour A, Zavvar R, Behjati M, Gharipour M:Predictive value of P wave duration and dispersion in post Coronaryartery bypass surgery atrial fibrillation. ARYA Atherosclerosis. 2012;8:59-62.
26. Altun A, Erdogan O, Tatli E, Ugur-Altun B, Durmus-Altun G, Ozbay G.Increased P wave dispersion: a new finding in patients with syndromeX. Can J Cardiol. 2002;18:1207-1210.
27. Ariyarajah V, Malinski M, Khadem A, Harizi R, Wolfe K, SpodickDH. Relation of recurrence of atrial fibrillation after nonST-elevationacute myocardial infarction to left atrial abnormality. Am J Cardiol.2008;101:30-34.
28. Eggers KM, Hjort M, Baron T, et al. Morbidity and cause-specificmortality in first-time myocardial infarction with nonobstructivecoronary arteries. J Intern Med. 2019;285(4):419-428.
29. Gorenek B, Kudaiberdieva G. Atrial fibrillation in acute ST-elevationmyocardial infarction: clinical and prognostic features. Curr CardiolRev. 2012;8(4):281-289.
30. El-Shetry M, Mahfouz R, Frere AF, Abdeldayem M. The interplaybetween atrial fibrillation and acute myocardial infarction. Br J HospMed (Lond). 2021;82(2):1-9.
31. Jons C, Joergensen RM, Hassager C, et al. Diastolic dysfunction predictsnew-onset atrial fibrillation and cardiovascular events in patients withacute myocardial infarction and depressed left ventricular systolicfunction: a CARISMA substudy. Eur J Echocardiogr. 2010; 11: 602-607.
32. Aronson D, Mutlak D, Bahouth F, et al. Restrictive left ventricularfilling pattern and risk of new-onset atrial fibrillation after acutemyocardial infarction. Am J Cardiol. 2011;107:1738-1743.
33. Yilmaz R, Kasap H, Baykan M, et al. Assessment of left ventricularfunction by Doppler tissue imaging in patients with atrial fibrillationfollowing acute myocardial infarction. Int J Cardiol. 2005;102:79-85.
34. Rodrigues AB, Gismondi RA, Lagoeiro A, et al. Association betweenB-type natriuretic peptide and within-visit blood pressure variability.Clin Cardiol. 2018;41(6):778-781.
35. Hwang HJ, Ha JW, Joung B, et al. Relation of inflammation and leftatrial remodeling in atrial fibrillation occurring in early phase of acutemyocardial infarction. Int J Cardiol. 2011;146:28-31.
36. Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive proteinand new-onset atrial fibrillation in patients with acute myocardialinfarction. Am J Cardiol 2007;100:753-757.
37. Yilmaz Y, Kelesoglu S, Elcik D, Ozmen R, Kalay N. Predictive Valuesof Systemic Immune-Inflammation Index in New-Onset AtrialFibrillation Following Coronary Artery Bypass Grafting. Braz JCardiovasc Surg. 2023;38(1):96-103.
38. Ulus T, Isgandarov K, Yilmaz AS, Vasi I, Moghanchızadeh SH, Mutlu F.Predictors of new-onset atrial fibrillation in elderly patients with acutecoronary syndrome undergoing percutaneous coronary intervention.Aging Clin Exp Res. 2018;30(12):1475-1482
39. Liu L, Gan S, Li B, Ge X, Yu H, Zhou H. Fisetin Alleviates AtrialInflammation, Remodeling, and Vulnerability to Atrial Fibrillationafter Myocardial Infarction. Int Heart J. 2019;60(6):1398-1406.
40. Chang CM, Wu TJ, Zhou S, et al. Nerve sprouting and sympathetichyperinnervation in a canine model of atrial fibrillation produced byprolonged right atrial pacing. Circulation. 2001;103:22-25.
41. Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, OlginJE. Atrial fibrillation produced by prolonged rapid atrial pacingis associated with heterogeneous changes in atrial sympatheticinnervation. Circulation. 2000;101:1185-1191.